SG2918

SG2918 · Hangzhou Sumgen Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SG2918, covering 2026-03-06 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: SG2918 For Advanced Malignant Tumors [Phase 1]